|
Reference #:
2006-189
Inventors/Contributors
George Vasmatzis Ph.D., John C. Cheville M.D., Farhad Kosari Ph.D., Cemile D. Savci Heijink M.D., Jan Marie A. Willard Munz, Eric W. Klee Ph.D., Lori S. Tillmans
Description
A set of prognostics markers for PCa has been identified using novel bioinformatics algorithms which analyze gene expression profiling data of PCa. These genes were selected because they were up-regulated in a sub-set of PCa cases with high Gleason grades. We have validated these markers using archived PCa tissues from a group of patients with known outcome. Expression of these genes, as determined by qRT-PCR on formalin fixed and paraffin embedded tissue correlates with aggressiveness of primary PCa tumors.
Patent Status
Pending |
|
Contact
Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 538-1652
Fax: (507) 284-5410
|
|
|
